Videos

Shared insight on technical processes and protocols used to manage patients with psoriatic arthritis, including those for prescription fulfillment.

A brief overview on the drivers of noncompliance and treatment adherence in patients with psoriatic arthritis.

Types of patient populations at higher risk for developing more severe forms of lupus.

Criteria used by rheumatologists to help classify lupus due to its heterogenous manifestation.

Rheumatology Network interviewed Jeffrey Stark, MD, to discuss the BE COMPLETE study, which examined the efficacy of bimekizumab for treating psoriatic arthritis.

Expert John Sergent, MD, goes into detail about myositis and how to differentiate it from other inflammatory diseases.

These prominent leaders in the field of autoimmune disease discuss AHN's Autoimmunity Institute joining forces with the Relapsing Polychondritis Foundation.

Expert perspectives on the importance of establishing good patient-provider relationships while managing psoriatic arthritis.

Reflections on the challenges inherent in managing psoriatic arthritis, particularly cost of care and educating patients on their disease.

Why is Rare Disease Day so important? Hear the answers from some of the most qualified professionals in rare disease fields.

Uma Mahadevan, MD, gives Rheumatology Network an overview of her Rheumatology Winter Clinical Symposium presentation, “Gastroenterology Update for the Rheumatologist.”

Anisha Dua, MD, MPH, discusses the mimics, related conditions, and new diseases in the field of vasculitis as it relates to rheumatology.

Vibeke Strand, MD, shares that based on her data, secukinumab is an effective option for treating patients with psoriatic arthritis.

Experts delve into considerations regarding management of comorbidities in patients with psoriatic arthritis.

John Tesser, MD; Nehad Soloman, MD; and Jennifer Simpson, DNP, talk about the importance of patient communication and the role of advanced practice clinicians.

Roy Fleishmann, MD, discusses his Rheumatology Winter Clinical Symposium presentation, “Beyond the package insert: JAK inhibitors (jakinibs): safety issues.”

The Chair of the ACR COVID-19 Vaccine Clinical Guidance Task Force shares what was learned from the Omicron variant and how the recommendations for rheumatologists has been affected by it.

Experts consider optimal treatment strategies for patients with treatment-resistant psoriatic arthritis.

An overview of treatment strategies and multimodality care essential to the management of psoriatic arthritis.

Roy Fleishmann, MD, discusses his Rheumatology Winter Clinical Symposium presentation, “SLE Update: Novel treatments, and how we assess them.”

Chair of the ACR COVID-19 Vaccine Clinical Guidance Task Force, Jeffrey Curtis, discusses the newest vaccine recommendations amid the Omicron variant.

Vibeke Strand explains that secukinumab improves psoriatic arthritis in patients regardless of their treatment history.

Shared insight on the role that nurse practitioners and advanced practice care providers have in the management of patients with psoriatic arthritis.

Experts review the pathophysiology of psoriatic arthritis and share their perspective on how it can impact patients and caregivers.

Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a Network Meta-Analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.

A panel of experts discuss the presentation of psoriatic arthritis and domains of disease.

John Tesser, MD; Nehad Soloman, MD; and Jennifer Simpson, DNP, review the pathophysiology of psoriatic arthritis.

Mary Wheatley, IOM, CAE, discusses the National Scleroderma Foundation, its recent name change, and the importance of raising awareness of this rare rheumatic condition.

Chengappa Kavadichanda, MD, discusses his study, “Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.”

W. Benjamin Nowell, PhD, Director, Patient-Centered Research, CreakyJoints, discusses his study, "Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower® Registry.”